Epilepsy Talk

$112 billion new Alzheimer’s drug in question

July 13, 2021
4 Comments

Getting the FDA to retract a decision is like getting the toothpaste back in the tub, after it’s been squeezed out…

Whether it’s “yes” or “no,” there is no “maybe so”.

A good example is the new all star Alzheimer’s drug aducanumab.


    About the author

    Phylis Feiner Johnson

    Phylis Feiner Johnson

    I've been a professional copywriter for over 35 years. I also had epilepsy for decades. My mission is advocacy; to increase education, awareness and funding for epilepsy research. Together, we can make a huge difference. If not changing the world, at least helping each other, with wisdom, compassion and sharing.

    View Full Profile →

    Enter your email address to follow this blog and receive free notifications of new posts by email.

    Join 3,124 other followers

    Follow Epilepsy Talk on WordPress.com